New developments in the diagnosis and treatment of axial spondyloarthritis

摘要: Spondyloarthritis (SpA) is an umbrella term for a group of diseases sharing genetic, molecular, immunological, clinical and imaging features. The last few years have witnessed remarkable progress in the understanding SpA. Notable advances include recognition MRI as sensitive specific tool detecting axial inflammation recent development validation Assessment International Society classification criteria predominantly peripheral This approach has advantage better describing disease, allowing earlier identification treatment non-radiographic forms potentially leading to improved outcomes. TNF α-blockers, which dramatically improve symptoms signs patients with ankylosing spondylitis, are now being tested SpA, first studies providing evidence that form disease also benefit from this...